http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2045532-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7570d8d27c24a8e26d761bb196fa5eaa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2be9d9c2a4e8064c74249453fc3afcef
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-234
filingDate 1988-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1995-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f2ef5115ad4c648863cc7f232159411
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0b9e4dc368d5302f780c3f28ee0c9ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5332df9a72758990787536f5f0eb6a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1556103e8cefffbcacb3ba2bc4bd8e7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36333426dfbfaa3af326d3133f08d805
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c540cbf0c65c6ba8afdc1c53d7e2d80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6c0234d95f26164f858ab61de3e4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f9dae3f9a4e76331bafcfc21d4ab297
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cb1d432f00f014670330935c0b012ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46dc2b65a7d24233c562983d56e90c6c
publicationDate 1995-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2045532-C1
titleOfInvention Process for preparing amicacin as sulfuric acid addition salts
abstract FIELD: chemical industry. SUBSTANCE: the product: amicacin sulfate. Reagent 1: an anhydrous complex of 3,6-di-N-benzylo-xycarbonyl kanamycin A with a divalent metal, possibly "in situ". Reagent 2: sulfuric acid. Reaction conditions: reagent 1 is polysilated in anhydrous DMFA, DMSO, pyridine or hexamethylsilazane, optionally by addition of dipicolinic acid or 3-hydroxypyridine. The resulting polysilyl derivative is subjected to reaction of (a) partial hydrolysis using water or alcohol in an amount of 3.3 to 10% with respect to the solvent and there-after acylated with N-hydroxysuccinimide ester of L-(-)-alpha-benzyloxycarbonylamine- alpha-hydroxybutyric acid and (b) hydrogenolysis in water with the addition of methanol at a pH of 1-3, preferably 1.5-2. After purification on ionites and removal of the solvent, sulfuric acid is successively added to adjust a pH to 1-5, preferably 1-2 and alcohol, preferably methanol, in an amount of 20-50% preferably 25-40% of the volume of the aqueous phase. The desired product is of high purity and meets the requirements for substances used as injection solutions. The yield is 49-82% The biological activity is 723 mg/mg per dry matter. EFFECT: more efficient preparation process.
priorityDate 1987-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448981304
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22242641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10394
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID177717
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447810228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544653
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11266
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517707
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521592
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37768
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416155195
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7937
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10367
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2724192
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13838
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1117
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483899
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19096565
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449603119
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519623
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6228
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733930
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419482702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448934265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583531
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25010735
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962

Total number of triples: 65.